~~<i id='312DE4FBBC'><strike id='312DE4FBBC'><tt id='312DE4FBBC'><pre id='312DE4FBBC'></pre></tt></strike></i>~~

Home» comprehensive» leisure time

leisure time

author：knowledge 2025-09-30 05:50:06 Page View：24

Adam's take main illustration — Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： There's no autism epidemic. It's an autism diagnosis epidemic
Next article： Medicare details structure of new drug price negotiation program

explore

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

After a decade, new Gardasil ad campaign gets it (mostly) right

Screengrabviaversedhpv.comWhileclickingthroughSnapchattheotherday,anadforMerck’snewVersedcampaignfor

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Steward Health Care has deal to sell doctor network to UnitedHealth

SuzanneKreiter/BostonGlobeTroubledhospitaloperatorStewardHealthCare,grapplingwithafinancialcrisistha